MicroRNA and Cancer: Tiny Molecules with Major Implications
Journal:
Current Genomics
Volume:
9
Page:
97-109
Author(s):
Timothy G. VandenBoom II, Yiwei Li, Philip A. Philip and Fazlul H. Sarkar
AGE-RAGE System and Carcinogenesis
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
940-945
Author(s):
Riichiro Abe and Sho-ichi Yamagishi
Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
969-972
Author(s):
Hideyuki Hyogo and Sho-ichi Yamagishi
Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
990-1000
Author(s):
Shu-Feng Zhou
Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1098-1112
Author(s):
B. Spankuch and K. Strebhardt
Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1143-1150
Author(s):
J. Stankova, A. K. Lawrance and R. Rozen
Hormone Replacement Therapy and Stroke
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
112-123
Author(s):
Antonia M.R. Billeci, Maurizio Paciaroni, Valeria Caso and Giancarlo Agnelli
Estrogen Receptor: Structural Differences and Potential Implications on Selectivity Examined by the GRID/CPCA Approach
Journal:
Letters in Drug Design & Discovery
Volume:
5
Page:
182-192
Author(s):
I. R.A. de Menezes, A. Leitao and C. A. Montanari
Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Journal:
Current Proteomics
Volume:
5
Page:
35-44
Author(s):
Olga Golubnitschaja
PET and SPECT Imaging of Tumor Biology: New Approaches Towards Oncology Drug Discovery and Development
Journal:
Current Computer-Aided Drug Design
Volume:
4
Page:
46-53
Author(s):
Marcian E. Van Dort, Alnawaz Rehemtulla and Brian D. Ross